Original Article
Is 25(OH)D Associated with Cognitive Impairment and Functional Improvement in Stroke? A Retrospective Clinical Study

https://doi.org/10.1016/j.jstrokecerebrovasdis.2015.03.007Get rights and content

Background

In recent years, vitamin D deficiency has been suggested as a risk factor for ischemic stroke and stroke severity in both animal models and clinical studies. In this retrospective study, we investigated the relationship between 25-hydroxyvitamin D [25(OH)D] levels and functional outcomes in stroke patients during neurological rehabilitation program. We also investigated whether there is an association between 25(OH)D levels and cognitive impairment.

Methods

The study included the medical records of 120 stroke patients who participated in a neurological rehabilitation program. The motor and cognitive components of the Functional Independence Measurements of all patients at admission and discharge were recorded. The Functional Ambulatory Scale was used to assess motor functional status, and the Turkish-validated version of the minimental state examination test was used to assess cognitive status.

Results

A significant correlation was found between 25(OH)D level and cognitive impairment among patients who had ischemic strokes. High levels of 25(OH)D were associated with greater functional gain during the rehabilitation program in both ischemic stroke patients and hemorrhagic stroke patients.

Conclusions

High 25(OH)D levels might be associated with greater functional improvement and with less cognitive impairment in stroke patients.

Introduction

The hormone vitamin D is essential for calcium metabolism and bone homeostasis. It has also been reported that vitamin D plays an important role in immune modulation, cell proliferation and differentiation, and regulation of cell growth.1 Generally speaking, vitamin D is biologically inactive; to be activated, it must be hydroxylated to 25-hydroxyvitamin D [25(OH)D] in the liver and to 1,25(OH)D in the kidney, which has the highest affinity for vitamin D receptors (VDRs). Although 1α hydroxylation of vitamin D occurs in the kidney, it has been shown that this process might occur locally in different cells and organs as well.2 Thus, measuring 25(OH)D is the best method for estimating the entire vitamin D status.2, 3

Poor vitamin D status is a public health problem, and low levels of this vitamin have been associated with cardiovascular disease and reported as a predictive factor for stroke.1, 4 Experimental studies have shown that vitamin D can prevent neurons from excitotoxic injury5 and that VDRs are activated by cerebral ischemia in animal models and in human stroke patients.6

Although several studies have reported a relationship between low vitamin D levels and an increased risk of stroke, only a few studies have reported low vitamin D levels as a predictor of high mortality and poor functional outcomes in the early stages of stroke.7 In this study, we investigated whether functional outcomes after neurological rehabilitation and cognitive impairment in individuals with stroke correlated with their plasma 25(OH)D levels. We hypothesized that low 25(OH)D levels in stroke patients are associated with less functional gain after neurological rehabilitation and greater cognitive impairment.

Section snippets

Materials and Methods

This study included the medical records of stroke patients who underwent an inpatient rehabilitation program between 2012 and 2014 and whose blood 25(OH)D levels were determined. Stroke diagnoses were determined for all patients using magnetic resonance imaging or computed tomography records. Chemiluminescent microparticle immunoassay with automated instruments was used to estimate the 25(OH)D levels. Criteria for exclusion included no recorded 25(OH)D levels, occurrence of stroke more than

Demographic Characteristics and Education Levels of the Patients

The ages, genders, and disease histories of the patients in the ischemic and hemorrhagic subgroups were similar (P > .05) (Table 1). Eighty percent of the patients were ischemic (n = 96), and 20% were in the hemorrhagic group (n = 24). The education levels of the patients in the ischemic group were lower than those in the hemorrhagic group (P < .05). The demographic data and comorbidities of the patients are summarized in Table 1.

Stroke Clinical Findings and Functional Outcomes

There were no differences between the ischemic and hemorrhagic

Discussion

Low vitamin D status has been associated with an elevated risk for cardiovascular, autoimmune, and infectious diseases.9, 10, 11, 12, 13, 14 In recent reports, vitamin D deficiency has been identified as a risk factor for ischemic stroke and has been found to be associated with the comorbidities that are traditional risk factors for ischemic stroke.4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15 Whereas several studies emphasizing 25(OH)D as a risk factor for ischemic stroke have been published, few

Conclusion

Vitamin D might play an important role in predicting rehabilitation outcome and cognition in stroke patients. The results of our study suggest that individuals with lower 25(OH)D levels have worse rehabilitation outcomes and poorer cognitive function than individuals with higher levels of 25(OH)D. More studies are needed to identify the role of vitamin D on functional outcome following the neurological rehabilitation process and on the cognitive functions of stroke patients. Investigating

References (30)

  • M. Peterlik et al.

    Vitamin D and calcium deficits predispose for multiple chronic diseases

    Eur J Clin Invest

    (2005)
  • M.F. Holick

    Vitamin D deficiency

    N Engl J Med

    (2007)
  • P. Brøndum-Jacobsen et al.

    25-Hydroxyvitamin D and symptomatic ischemic stroke: an original study and meta-analysis

    Ann Neurol

    (2013)
  • R. Balden et al.

    Vitamin D deficiency exacerbates experimental stroke injury and dysregulates ischemia-induced inflammation in adult rats

    Endocrinology

    (2012)
  • B. Daubail et al.

    Serum 25-hydroxyvitamin D predicts severity and prognosis in stroke patients

    Eur J Neurol

    (2013)
  • Cited by (0)

    The author(s) declare(s) that there are no conflict of interests regarding the publication of this paper.

    The authors have no financial disclosures.

    View full text